RIF1 and ovarian carcinoma: Additionally, analysis of epithelial ovarian cancer tissue revealed that nearly two out of three patients with chemoresistant epithelial ovarian cancer had high expression of RIF1, whereas only 34.2% of chemosensitive patients displayed overexpression of RIF1 [158].